| Patents for A61P 33 - Antiparasitic agents (21,787) |
|---|
| 08/14/2003 | WO2001092527A3 Regulators of apoptosis |
| 08/14/2003 | US20030153727 Controlling protein levels in eucaryotic organisms |
| 08/14/2003 | US20030153568 Serine/threonine and tyrosine kinases inhibitors |
| 08/14/2003 | US20030153544 Fatty acid derivatives |
| 08/14/2003 | US20030153533 Novel phospholipid derivatives |
| 08/14/2003 | US20030153523 Screening library of test compounds, each of which is attached to a solid support, with a dye-labeled RNA molecule to form a dye-labeled target RNA:support-attached test compound complex |
| 08/14/2003 | US20030153500 Use of EGF to inhibit pathogenic infections |
| 08/14/2003 | US20030153073 Expansion of T cells in vitro and expanded T cell populations |
| 08/14/2003 | CA2475247A1 Anti-pathogen treatments |
| 08/14/2003 | CA2474709A1 Immunostimulatory, covalently lipidated oligonucleotides |
| 08/14/2003 | CA2471207A1 Method of inhibiting pathogenicity of infectious agents |
| 08/14/2003 | CA2466251A1 Therapeutic use of aziridino compounds |
| 08/13/2003 | EP1335023A2 Methods and reagents for vaccination which generate a CD8 T cell immune response |
| 08/13/2003 | EP1334970A1 Novel ft-0554a substances and process for the preparation thereof |
| 08/13/2003 | EP1334717A2 Pharmaceutical Compositions For Oral And Topical Administration |
| 08/13/2003 | EP1334187A2 C. elegans genes involved in viability and/or reproduction and uses thereof |
| 08/13/2003 | EP1334094A1 Cholesterol lowering benzo[b]thiophenes and benzo[d]isothiazoles |
| 08/13/2003 | EP1333841A2 M. tuberculosis chaperonin 10 and uses thereof |
| 08/13/2003 | EP1333840A2 M. tuberculosis chaperonin 60.1 and uses thereof |
| 08/13/2003 | EP1152768B1 Treatment of chronic viral infections with m. vaccae |
| 08/13/2003 | EP1143981A4 Treatment and prevention of hiv and other viral infections |
| 08/13/2003 | CN1436180A Diamino phenothiazine derivs. and composition comprising same |
| 08/13/2003 | CN1436168A Beta-amino acid nitrile derivs. |
| 08/13/2003 | CN1436047A Compositions and methods for improving vascular health |
| 08/13/2003 | CN1435176A Triclabendazole-contg. preparation based on surfactant |
| 08/13/2003 | CN1117753C Substd. benzimidazoles, production and use thereof as agents for combating parasitic protozoas |
| 08/12/2003 | US6605730 3-(2-Thienyl)-5-phenyl-1H-pyrazole compounds of given formula |
| 08/12/2003 | US6605595 Higher antiparasitic activity |
| 08/12/2003 | US6605449 Saturation mutagenesis to produce progenitor polynucleotide library |
| 08/07/2003 | WO2003064475A1 Novel monoclonal antibody and nematode larval antigens |
| 08/07/2003 | WO2003063858A2 Compounds, particularly of urea derivatives or ester derivatives of haloacetamidobenzoic acid and use thereof for the treatment of parasitic diseases |
| 08/07/2003 | WO2003063838A1 Dry granulated formulations of azithromycin |
| 08/07/2003 | WO2003063767A2 Rsv proteins, antibodies, compositions, methods and uses |
| 08/07/2003 | US20030149237 G-protein coupled receptor for treatment and prevention of eating, cancer, autoimmune, vision and nervous sytem disorders; antiinflammatory agents |
| 08/07/2003 | US20030149090 Topically delivering an effective dose of a reactvie oxygen metabolites (ROM) production and release inhibitory compound in carrier to a subject suffering from ROM-mediated oxidative damage |
| 08/07/2003 | US20030149057 Anti-cancer compounds |
| 08/07/2003 | US20030148890 Organic compounds |
| 08/07/2003 | US20030148264 PDZ (PSD-95/Discs large/ZO-I) domains, (PSD-95 = post-synaptic density protein-95); PDZ proteins involved in assembling ion channels and other transmembrane receptors, at specialized subcellular sites such as tight junctions |
| 08/07/2003 | CA2474809A1 Dry granulated formulations of azithromycin |
| 08/07/2003 | CA2474240A1 Novel monoclonal antibody and nematode larval antigens |
| 08/07/2003 | CA2466025A1 Rsv proteins, antibodies, compositions, methods and uses |
| 08/06/2003 | EP1332209A2 Collections of repeat proteins comprising repeat modules |
| 08/06/2003 | EP1332146A2 Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 08/06/2003 | EP1331928A2 Particle formation methods and their products |
| 08/06/2003 | EP1140152B1 Method to produce inactivated w/o emulsion adjuvated vaccines |
| 08/06/2003 | EP1109811B1 Pyrrolobenzodiazepines |
| 08/06/2003 | CN1434823A 3-thiazol-4-yl-pyprolidine derivatives as AMP-specific phosphodiesterase inhibitors |
| 08/06/2003 | CN1434813A Pyrrolidine derivatives cyclic AMP-specific phosphodiesterase inhibitors |
| 08/06/2003 | CN1434799A Cyclic amp-specific phosphodiesterase inhibitors |
| 08/06/2003 | CN1434798A Pyrrolidines which inhibit CAMP-specific PDE |
| 08/06/2003 | CN1434797A Hydrazone and oxime derivatives of pyrrolidine as AMP-specific phosphodiesterase inhibitons |
| 08/06/2003 | CN1434795A Acyl pseudodipeptides which carry a functionalised auxiliary arm |
| 08/06/2003 | CN1434705A Use of hydroxide-releasing agents as skin permeation enhancers |
| 08/05/2003 | US6603046 The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria. |
| 08/05/2003 | US6602872 Substituted pyridazines having cytokine inhibitory activity |
| 08/05/2003 | US6602862 1-Amino-alkylcyclohexanes as trypanocidal agents |
| 08/05/2003 | US6602296 Chemical supplementation of bone |
| 07/31/2003 | WO2003061672A1 Method of treatment of gastrointestinal disease and polymeric composition for use therein |
| 07/31/2003 | WO2003061669A1 Use of alkylphosphocholines for the preventative treatment of protozoan diseases |
| 07/31/2003 | WO2003032911A3 Anti-angiogenic and cytotoxic fused pyrimidines |
| 07/31/2003 | WO2002060875A8 Nicotinamide biaryl derivatives useful as inhibitors of pde4 isozymes |
| 07/31/2003 | WO2002051410A3 Phenylthiazole and thiazoline derivatives and their use as antiparasitics |
| 07/31/2003 | WO2001034566A3 Protease inhibitors |
| 07/31/2003 | US20030144302 Process for making substituted pyrazoles |
| 07/31/2003 | US20030144293 N-alkyl-adamantyl triazinyl benzamide derivatives |
| 07/31/2003 | US20030144283 Amide substituted imidazoquinolines |
| 07/31/2003 | US20030144279 5-Heterocyclo-pyrazoles |
| 07/31/2003 | US20030144249 Aminoalkylenephosphoxide derivatives, useful as bactericide, fungicide, viricide and parasiticide |
| 07/31/2003 | US20030144210 Treatment of neurologic and psychiatric disorders |
| 07/31/2003 | US20030143672 Providing conservative or semi-conservative amino acid substitutions at positions 3 and/or 5 and/or 7 of these epitopes, useful in eliciting immune responses with respect to corresponding wildtype epitopes |
| 07/31/2003 | US20030143589 Drug metabolizing enzymes |
| 07/31/2003 | US20030143234 For therapy of microbial organism infection |
| 07/31/2003 | CA2470185A1 Use of alkylphosphocholines in the prevention of protozoal diseases |
| 07/30/2003 | EP1330537A1 Membrane fractions of 1,2-sn-diacylglycerol-enriched cells |
| 07/30/2003 | EP1330455A1 Novel 7-azaindoles, use thereof as phosphodiesterase 4 inhibitors and method for producing the same |
| 07/30/2003 | EP1252141B1 Tosylproline analogs as thymidylate synthase inhibitors |
| 07/30/2003 | EP0859628B1 Drug, in particular for modulating the immunological response for the control of viruses, tumours, bacteria and parasites |
| 07/30/2003 | EP0697814B1 Pour-on formulations containinng polymeric material, glycols and glycerides |
| 07/30/2003 | CN1433480A Feeding assay for identifying nematicidal compounds |
| 07/30/2003 | CN1433412A Novel tetrahydropyridines, preparation method and pharmaceutical compositions containing same |
| 07/30/2003 | CN1433319A Enzyme treatment for infection |
| 07/30/2003 | CN1432364A Veterinary hematocytozoon resisting medicine capsule and its prepn |
| 07/30/2003 | CN1432357A Fever allaying prepn containing xylitol |
| 07/30/2003 | CN1116076C Compisition for prevention and treatment of helminth infections |
| 07/30/2003 | CN1116034C Acyl urea compounds for treatment of coccidioidomycosis in warmblooded animals |
| 07/29/2003 | US6600059 Protecting cells from injury due to intrinsic membrane lysis, oxidation and/or invasion by destructive agents. Even more particularly, the present invention provides compositions and methods for treating or prophylactically inhibiting |
| 07/29/2003 | US6600027 Polynucleotide molecules encoding neospora proteins |
| 07/29/2003 | US6599706 Recombinant PR-3 and assays employing the same |
| 07/24/2003 | WO2003060118A1 Iron-sulfur protein, protein-fad complex, electron transporter and method of measuring the inhibition of ferredotoxin activity |
| 07/24/2003 | WO2003059897A1 Thiadiazole compounds and use thereof |
| 07/24/2003 | WO2003059891A1 Substituted pyridazinones as inhibitors of p38 |
| 07/24/2003 | WO2003059881A2 Dna minor groove binding compounds |
| 07/24/2003 | WO2003059880A1 Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these |
| 07/24/2003 | WO2003059868A1 Amidoacetonitrile derivatives |
| 07/24/2003 | WO2003059352A2 Use of a novel class of drugs for the treatment of parasitic diseases |
| 07/24/2003 | WO2003048168A3 Trioxane derivatives as antimalaria or anticancer compounds |
| 07/24/2003 | US20030139597 Novel Cyclic hydroxamic acid as metalloproteinase inhibitors |
| 07/24/2003 | US20030139590 Comprises nucleotide sequences coding orphan receptor 25 for detecting modulators of platelet activating factor (PAF) activity; antiinflammatory agents; gene/translation inhibition; drug screening |
| 07/24/2003 | US20030139459 Oral combination of lufenuron and nitenpyram against fleas |
| 07/24/2003 | US20030139453 Difluorobutyric acid metalloprotease inhibitors |